EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

METTL3 Modulates Radiation‐Induced Cardiac Fibrosis via the Akt/ mTOR Pathway

Shunsong Qiao iD, Chao Tang, Jingjing Zhu, Yu Feng, Li Xiang, Jing Zhu, Xiaosong Gu iD

The FASEB Journal · 15.06.2025 · 39 (11)

DOI: 10.1096/fj.202403143rrrr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 05.06.2025. Verfasst von Shunsong Qiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Methyltransferases, Proto-Oncogene Proteins c-akt, Myocardium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academic Lifts Project of the Second Affiliated Hospital of Soochow University, Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University, Second Affiliated Hospital of Soochow University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While thoracic radiotherapy represents a mainstay therapeutic modality for malignancies, its cardiotoxic sequelae, particularly radiation‐induced cardiac fibrosis (RICF), significantly limit clinical outcomes. Emerging evidence implicates the N6‐methyladenosine (m6A) methyltransferase METTL3 in pathological cardiac remodeling, though its mechanistic involvement in radiation‐associated fibrogenesis remains enigmatic. This investigation elucidates the epigenetic regulation of METTL3 in RICF pathogenesis. X‐ray‐modulated RICF mice models were constructed to investigate the role of METTL3 in cardiac fibroblasts. Simultaneously, METTL3 overexpression and silencing were conducted on fibroblasts and mice hearts to evaluate pro‐fibrotic protein expression, cardiac fibrosis, and heart function. Radiation impairs cardiac function and induces myocardial fibrosis. Elevated METTL3 expression was observed in irradiated mouse hearts and cardiac fibroblasts. During irradiation, METTL3 promoted fibroblast proliferation and differentiation into myofibroblasts. Overexpression of METTL3 in cardiac fibroblasts was associated with increased expression of pro‐fibrotic proteins and intensified fibrosis, and silencing of METTL3 attenuated these adverse effects. Mechanistically, METTL3 promotes m6A modification of Akt mRNA and enhances its stability by recognizing the m6A‐reading protein IGF2BP1, which activates the Akt/mTOR signaling pathway to promote fibroblast proliferation and differentiation toward myofibroblasts, thereby inducing cardiac fibrosis. Furthermore, pharmacological administration of STM2457, a highly selective METTL3 inhibitor, effectively ameliorated cardiac fibrosis in mice. Our findings establish METTL3 as a novel epigenetic regulator of RICF through m6A‐Akt/mTOR axis activation. The demonstrated efficacy of METTL3‐targeted intervention provides mechanistic justification for developing precision cardioprotective strategies during radiotherapy. This work advances our understanding of epitranscriptomic control in radiation‐associated cardiotoxicity and highlights the translational potential of m6A‐targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesMethyltransferasesProto-Oncogene Proteins c-aktMyocardiumAnimalsFibrosisMiceSignal TransductionFibroblastsMaleMice, Inbred C57BLCell Proliferation

Stichwörter der Autor:innen

Akt signalingMETTL3heart failuremyocardial fibrosisradiation

Substanzen

TOR Serine-Threonine KinasesMethyltransferasesProto-Oncogene Proteins c-aktmTOR protein, mouseMettl3 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Rheumatology and Immunology, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.

ORCID-Profile: Shunsong Qiao, Xiaosong Gu

Förderung

  • Academic Lifts Project of the Second Affiliated Hospital of Soochow University
  • Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University
  • Second Affiliated Hospital of Soochow University
  • National Natural Science Foundation of China

Zitieren

APA

Qiao, S., Tang, C., Zhu, J., Feng, Y., Xiang, L., Zhu, J., & Gu, X. (2025). METTL3 Modulates Radiation‐Induced Cardiac Fibrosis via the Akt/ mTOR Pathway. The FASEB Journal, 39(11). https://doi.org/10.1096/fj.202403143rrrr

Vancouver

Qiao S, Tang C, Zhu J, Feng Y, Xiang L, Zhu J, et al. METTL3 Modulates Radiation‐Induced Cardiac Fibrosis via the Akt/ mTOR Pathway. The FASEB Journal. 2025;39(11). doi:10.1096/fj.202403143rrrr

BibTeX
@article{Qiao2025,
  author = {Qiao, Shunsong and Tang, Chao and Zhu, Jingjing and Feng, Yu and Xiang, Li and Zhu, Jing and Gu, Xiaosong},
  title = {METTL3 Modulates Radiation‐Induced Cardiac Fibrosis via the Akt/ mTOR Pathway},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {11},
  doi = {10.1096/fj.202403143rrrr}
}
Kostenlos starten →